According to the AAD-NPF joint guidelines, monitoring should be conducted as follows in patients taking biologics:
Periodic history and physical examination, including screening for nonmelanoma skin cancer
Specific assessment for infections
Exacerbation/development of inflammatory bowel disease
Tuberculosis testing in persons at high risk owing to travel or contact with an infected individual
An annual chest radiograph may be considered at the discretion of the treating dermatologist
Periodic assessment of suicidal ideation is recommended for patients treated with brodalumab and might necessitate more frequent follow-up visits
Follow-up visits can be scheduled from quarterly to twice yearly on the basis of time of treatment, response, and tolerability of the medication.
Follow Medscape on Facebook, Twitter, Instagram, and YouTube
Editor's Recommendations
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: David T. Robles. Skill Checkup: A 32-Year-Old Man With an Acute Flare of Psoriasis - Medscape - May 11, 2022.
Comments